Document Detail

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.
MedLine Citation:
PMID:  23292099     Owner:  NLM     Status:  Publisher    
PURPOSE: Lysosome-associated protein transmembrane 4 beta (LAPTM4B), a novel oncoprotein, has been shown to be overexpressed in several human malignancies. Our purpose was to evaluate the expression of LAPTM4B in breast carcinoma and its significance, which was not previously studied by others. METHODS: Through immunohistochemistry, LAPTM4B expression was evaluated in 35 benign breast tumor specimens and 194 breast cancer specimens. The correlation of LAPTM4B expression with clinicopathological parameters was assessed using χ (2) analysis. The survival status of patients was analyzed using the Kaplan-Meier and log-rank tests. Cox regression was used for the multivariate analysis of prognostic factors. RESULTS: The immunohistochemistry results showed that the expression level of LAPTM4B in breast cancer cases was significantly higher than that in benign breast tumor tissues (P < 0.001). Moreover, statistical analysis also showed that high LAPTM4B expression was positively related to TNM stage, lymph node metastasis, and recurrence. Furthermore, it was also shown that patients with high LAPTM4B expression had significantly poorer overall survival and disease-free survival compared with patients with low expression of LAPTM4B (P = 0.019 and P = 0.005, respectively). Multivariate Cox regression analysis revealed that high LAPTM4B expression level was an independent prognostic factor for both overall survival and disease-free survival of patients with breast cancer (P = 0.041 and P = 0.023, respectively). CONCLUSIONS: Overexpression of LAPTM4B may contribute to the tumor progression and poor prognosis of breast cancer, thus testing the expression of LAPTM4B will be helpful for predicting prognosis in breast cancer.
Min Xiao; Shusheng Jia; Hongbin Wang; Jinsong Wang; Yuanxi Huang; Zhigao Li
Related Documents :
23876209 - Change of mammographic density predicts the risk of contralateral breast cancer: a case...
24965939 - Breast cancer threat appraisal: design and psychometric analysis of a new scale for old...
3601799 - Neoplasm to neoplasm metastasis. pheochromocytoma harboring a metastasis of breast cancer.
7059199 - Cutaneous metastases from carcinoma of the cervix.
24665929 - Androgenetic alopecia and polymorphism of the androgen receptor gene (snp rs6152) in pa...
24165579 - No link between breast cancer and meningioma: results from a large monoinstitutional re...
21956469 - Immunohistochemical analysis of napi2b protein (mx35 antigen) expression and subcellula...
12353499 - Role of tgf-beta 1 and tgf-beta type ii receptor in gastric cancer.
18392689 - Immunotherapy for head and neck cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-6
Journal Detail:
Title:  Journal of cancer research and clinical oncology     Volume:  -     ISSN:  1432-1335     ISO Abbreviation:  J. Cancer Res. Clin. Oncol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902060     Medline TA:  J Cancer Res Clin Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Breast Surgery, The Affiliated Tumor Hospital of Harbin Medical University, Baojian Road 6, Nangang District, 150081, Harbin, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calo...
Next Document:  Opposite effects of weak transcranial direct current stimulation on different phases of short interv...